tiprankstipranks
Trending News
More News >
Advertisement

HOLA - ETF AI Analysis

Compare

Top Page

HOLA

JPMorgan International Hedged Equity Laddered Overlay ETF (HOLA)

Rating:69Neutral
Price Target:
HOLA, the JPMorgan International Hedged Equity Laddered Overlay ETF, earns a solid overall rating driven mainly by high-quality global leaders like AstraZeneca, Toyota, and ASML, which show strong financial performance, healthy earnings, and generally supportive valuations. The fund also benefits from stable blue chips such as Nestlé and Siemens, though some holdings like Safran and Allianz face profitability or bearish technical pressures that slightly weigh on the rating; overall, risks appear diversified across sectors and regions rather than concentrated in a single area.
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries in Europe and Asia-Pacific, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, technology, health care, and several other sectors, limiting reliance on just one part of the economy.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.
Negative Factors
Heavy Tilt Toward Financials
A large share of the portfolio is in financial stocks, which can make the fund more sensitive to banking and interest-rate risks.
Mixed Results Among Top Holdings
While some leading positions like ASML and Siemens have performed strongly, others such as AstraZeneca, Allianz, and Nestlé have been weak, creating uneven contribution to returns.
Limited U.S. Exposure
The fund has only a small allocation to U.S. stocks, so investors relying on U.S. market strength will not get much support from this ETF.

HOLA vs. SPDR S&P 500 ETF (SPY)

HOLA Summary

HOLA is an international stock ETF from JPMorgan that invests in companies outside the U.S., mainly in Japan, the UK, Germany, and France. It doesn’t track a set index, but instead is actively managed and uses strategies to try to smooth out ups and downs and hedge currency moves. The fund owns many well-known global companies such as ASML, Nestlé, and AstraZeneca, and spreads money across financials, industrials, tech, and health care, which can help with diversification and long-term growth. A key risk is that foreign stocks can still rise and fall sharply with global markets.
How much will it cost me?The expense ratio for the JPMorgan International Hedged Equity Laddered Overlay ETF (HOLA) is 0.30%, meaning you’ll pay $3 per year for every $1,000 invested. This is higher than average because the fund is actively managed and uses a sophisticated strategy, including currency hedging and options overlays, to reduce risk and enhance returns.
What would affect this ETF?HOLA's focus on global equities and its hedging strategy can benefit from stable international economic growth and a weakening U.S. dollar, which would enhance returns for foreign investments. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key sectors like financials and technology could negatively impact performance. Its exposure to diverse sectors and top holdings in companies like ASML and AstraZeneca provides resilience but also ties its success to sector-specific trends and global market stability.

HOLA Top 10 Holdings

HOLA leans heavily into Europe and other developed markets, with financials and industrials setting the tone. ASML is one of the main engines, rising on strong chip-equipment demand and giving the fund a tech-powered tailwind. Healthcare names like AstraZeneca and Roche are also pulling their weight, adding steady, defensive growth. On the flip side, Siemens has been a bit choppy lately and Allianz is losing steam, modestly dampening results. Overall, performance is being driven by a global mix of blue-chip leaders rather than a single superstar stock.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.04%$8.55M€458.38B86.92%
76
Outperform
AstraZeneca2.16%$6.08M$305.49B27.65%
80
Outperform
Shell (UK)1.75%$4.92M£179.19B24.58%
73
Outperform
Siemens1.50%$4.23M€176.96B2.09%
74
Outperform
Nestlé SA1.45%$4.08MCHF201.30B0.07%
71
Outperform
Banco Santander1.44%$4.06M€146.91B62.23%
73
Outperform
Roche Holding AG1.38%$3.89MCHF268.16B29.32%
73
Outperform
HSBC Holdings1.35%$3.80M£219.84B52.09%
80
Outperform
Novartis AG1.34%$3.77MCHF232.19B30.93%
80
Outperform
SAFRAN SA1.33%$3.75M€133.83B28.93%
67
Neutral

HOLA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
53.99
Negative
100DMA
52.55
Positive
200DMA
Market Momentum
MACD
-0.20
Positive
RSI
36.97
Neutral
STOCH
37.15
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HOLA, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 54.42, equal to the 50-day MA of 53.99, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.20 indicates Positive momentum. The RSI at 36.97 is Neutral, neither overbought nor oversold. The STOCH value of 37.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HOLA.

HOLA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$282.19M0.50%
69
Neutral
$743.95M0.55%
70
Neutral
$726.76M0.75%
61
Neutral
$522.14M0.62%
60
Neutral
$263.62M0.89%
61
Neutral
$253.26M0.72%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HOLA
JPMorgan International Hedged Equity Laddered Overlay ETF
53.29
5.17
10.74%
RGEF
Rockefeller Global Equity ETF
KAT
Scharf ETF
DWLD
Davis Select Worldwide Etf
JSTC
Adasina Social Justice All Cap Global ETF
NANC
Unusual Whales Subversive Democratic Trading ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement